Alnuctamab
- Generic Name
- Alnuctamab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 2296827-07-9
- Unique Ingredient Identifier
- 7OSV6M6T4D
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Phase 3
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Celgene
- Registration Number
- NCT06232707
- Locations
- 🇺🇸
Local Institution - 0088, Los Angeles, California, United States
🇺🇸Local Institution - 0324, Baltimore, Maryland, United States
🇦🇺Local Institution - 0022, Waratah, New South Wales, Australia
A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-12-11
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Celgene
- Target Recruit Count
- 156
- Registration Number
- NCT06163898
- Locations
- 🇺🇸
Local Institution - 0035, New Haven, Connecticut, United States
🇺🇸Local Institution - 0018, New York, New York, United States
🇺🇸Local Institution - 0033, Birmingham, Alabama, United States
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of BMS-986393 in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-08
- Last Posted Date
- 2024-12-20
- Target Recruit Count
- 111
- Registration Number
- NCT06121843
- Locations
- 🇺🇸
University Of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Local Institution - 0002, Phoenix, Arizona, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath